Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
Tavo Biotherapeutics has raised $17.0M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Tavo Biotherapeutics's investors include Polaris Partners, Tau Ventures, Pureos Bioventures.
Tavo Biotherapeutics is headquartered in Dorchester, United States.
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
Tavo Biotherapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tavo Biotherapeutics — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/tavo-biotherapeutics. Accessed November 13, 2026.
VCBacked. (2026). Tavo Biotherapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/tavo-biotherapeutics
{{cite web |title=Tavo Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavo-biotherapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Tavo Biotherapeutics? Request a listing update